Merck's COVID-19 pill shows lower efficacy in updated data

Redirecting to full article in 5 second(s)...

Merck said on Friday (Nov 26) that updated data from its study on its experimental COVID-19 pill showed the drug was less effective in cutting hospitalisations and deaths than previously reported. The drugmaker said its pill showed a 30 per cent reduction in hospitalisations and deaths, based on data